Registry (OCR) to identify all incident cases of colorectal cancer (CRC) in Ontario diagnosed in 2000 to 2008. The OCR does not capture disease stage for all patients; therefore, we obtained surgical pathology reports for a random sample of 25% of cases
Search Results
Natasha Satkunam, Xuejiao Wei, James J. Biagi, Sulaiman Nanji, and Christopher M. Booth
Dayna Crawford, Brook Blackmore, Jeremy Ortega, and Erica Williams
: By developing software that utilizes artificial intelligence, Sarah Cannon created an automated process to identify colon cancer patients at the time of diagnosis. This technology then routes positive pathology reports to a VCN who contacts the early
Yamini V. Ananth and Karisa Schreck
-based database using the REDCap tool. We analyzed data from 29 adults with primary brain tumors containing the BRAF V600E mutation, recording gender, age at diagnosis, tumor pathology, molecular tumor information, dates of surgeries, time to progression
Samantha Rios and Kelsey Larson
-up imaging and procedures, and final breast pathology were reviewed. Descriptive points were analyzed using counts and percentages versus mean with standard deviation where applicable. After review, 261 patients met inclusion and exclusion criteria with
Rafael López, Antonio Antón, Enrique Aranda, Alfredo Carrato, Manuel Constenla, Juan Jesús Cruz, Eduardo Díaz-Rubio, Margarita Feyjóo, Jesús García-Foncillas, Pere Gascón, Vicente Guillem, Ilse Lugo, Álvaro Rogado, and Carlos Camps
participation. Core and lung cancer modules were completed. Results: During the 6 rounds, 1,877 charts were submitted by the Spanish practices. In most of the rounds, the highest scores were: pathology report confirming malignancy; number of chemotherapy
Christopher M. Booth, Sulaiman Nanji, Xuejiao Wei, Yingwei Peng, James J. Biagi, Timothy P. Hanna, Monika K. Krzyzanowska, and William J. Mackillop
during 2000–2008. The OCR does not capture stage of disease for all patients; therefore, we obtained surgical pathology reports for a random sample of 25% of cases. Reports were not available for patients with surgery in 2005; therefore, the study cohort
Giuseppe Curigliano
.m. Patient: “Doctor, I’m terrified. The pathology report says ‘invasive carcinoma.’ ‘Invasive’ means cancer, doesn’t it? I’ll need chemotherapy. I’ll lose my hair. I won’t see my children grow up.” Across borders and social-cultural groups of patients, a
Siddhartha Yadav, Sri Harsha Tella, Anuhya Kommalapati, Kristin Mara, Kritika Prasai, Mohamed Hamdy Mady, Mohamed Hassan, Rory L. Smoot, Sean P. Cleary, Mark J. Truty, Lewis R. Roberts, and Amit Mahipal
diagnosis. 5 The current AJCC TNM staging system for GBC is primarily based on surgical pathology. 6 It relies on accurate evaluation of tumor infiltration into the layers of gallbladder, which can only be achieved through complete surgical excision of the
Robert W. Carlson, Elizabeth Brown, Harold J. Burstein, William J. Gradishar, Clifford A. Hudis, Charles Loprinzi, Eleftherios Paul Mamounas, Edith A. Perez, Kathleen Pritchard, Peter Ravdin, Abram Recht, George Somlo, Richard L. Theriault, Eric P. Winer, Antonio C. Wolff, and for the NCCN Adjuvant Therapy for Breast Cancer Task Force
ovarian pathology. This raises the issue of determining menopausal status at the start of, during, and after therapy. For example, patients may become amenorrheic during adjuvant chemotherapy without permanent loss of ovarian hormone production. Thus, the
D. Craig Allred, Robert W. Carlson, Donald A. Berry, Harold J. Burstein, Stephen B. Edge, Lori J. Goldstein, Allen Gown, M. Elizabeth Hammond, James Dirk Iglehart, Susan Moench, Lori J. Pierce, Peter Ravdin, Stuart J. Schnitt, and Antonio C. Wolff
translation? A systematic database of gene expression in breast cancer . Pathobiology 2008 ; 75 : 112 – 118 . 110 Allred DC . The utility of conventional and molecular pathology in managing breast cancer . Breast Cancer Res 2008 ; 10 ( Suppl
